I. Aifantis, E. Raetz, and S. Buonamici, Molecular pathogenesis of T-cell leukaemia and lymphoma, Nature Reviews Immunology, vol.204, issue.5, pp.380-390, 2008.
DOI : 10.1038/nri2304

E. Anastasi, A. Campese, D. Bellavia, A. Bulotta, A. Balestri et al., Expression of Activated Notch3 in Transgenic Mice Enhances Generation of T Regulatory Cells and Protects against Experimental Autoimmune Diabetes, The Journal of Immunology, vol.171, issue.9, pp.4504-4511, 2003.
DOI : 10.4049/jimmunol.171.9.4504

A. Barbarulo, P. Grazioli, A. Campese, D. Bellavia, D. Mario et al., Notch3 and canonical NF-{kappa}B signaling pathways cooperatively regulate Foxp3 transcription, 2011.

D. Bellavia, A. Campese, E. Alesse, A. Vacca, M. Felli et al., Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice, The EMBO Journal, vol.19, issue.13, pp.3337-3348, 2000.
DOI : 10.1093/emboj/19.13.3337

D. Bellavia, A. Campese, S. Checquolo, A. Balestri, A. Biondi et al., Combined expression of pT?? and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis, Proceedings of the National Academy of Sciences, vol.99, issue.6, pp.3788-3793, 2002.
DOI : 10.1073/pnas.062050599

D. Bellavia, M. Mecarozzi, A. Campese, P. Grazioli, C. Talora et al., Notch3 and the Notch3-upregulated RNA-binding protein HuD regulate Ikaros alternative splicing, The EMBO Journal, vol.17, issue.6, pp.1670-1680, 2007.
DOI : 10.1038/sj.emboj.7601626

L. Beverly, D. Felsher, and A. Capobianco, Suppression of p53 by Notch in Lymphomagenesis: Implications for Initiation and Regression, Cancer Research, vol.65, issue.16, pp.7159-7168, 2005.
DOI : 10.1158/0008-5472.CAN-05-1664

J. Bolden, M. Peart, and R. Johnstone, Anticancer activities of histone deacetylase inhibitors, Nature Reviews Drug Discovery, vol.106, issue.9, pp.769-784, 2006.
DOI : 10.1038/nrd2133

B. Jr and M. , Rational combinations using HDAC inhibitors, Clin Cancer Res, vol.15, pp.3970-3977, 2009.

M. Buchwald, O. Kramer, and T. Heinzel, HDACi ??? Targets beyond chromatin, Cancer Letters, vol.280, issue.2, pp.160-167, 2009.
DOI : 10.1016/j.canlet.2009.02.028

G. Canettieri, D. Marcotullio, L. Greco, A. Coni, S. Antonucci et al., Histone deacetylase and Cullin3???RENKCTD11 ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation, Nature Cell Biology, vol.416, issue.2, pp.132-142, 2010.
DOI : 10.1038/ncb2013

S. Checquolo, R. Palermo, S. Cialfi, G. Ferrara, C. Oliviero et al., Differential subcellular localization regulates c-Cbl E3 ligase activity upon Notch3 protein in T-cell leukemia, Oncogene, vol.162, issue.10, pp.1463-1474, 2010.
DOI : 10.1128/MCB.21.21.7403-7415.2001

E. Clappier, S. Collette, N. Grardel, S. Girard, L. Suarez et al., NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951, Leukemia, vol.83, issue.12, pp.2023-2031, 2010.
DOI : 10.1038/nm.1900

M. Felli, A. Vacca, A. Calce, D. Bellavia, A. Campese et al., PKC?? mediates pre-TCR signaling and contributes to Notch3-induced T-cell leukemia, Oncogene, vol.24, issue.6, pp.992-1000, 2005.
DOI : 10.1038/sj.onc.1208302

L. Galbiati, R. Mendoza-maldonado, M. Gutierrez, and M. Giacca, Regulation of E2F-1 after DNA Damage by p300-Mediated Acetylation and Ubiquitination, Cell Cycle, vol.4, issue.7, pp.930-939, 2005.
DOI : 10.4161/cc.4.7.1784

C. Grozinger and S. Schreiber, Deacetylase Enzymes, Chemistry & Biology, vol.9, issue.1, pp.3-16, 2002.
DOI : 10.1016/S1074-5521(02)00092-3

V. Guarani, G. Deflorian, C. Franco, M. Kruger, L. Phng et al., Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase, Nature, vol.248, issue.7346, pp.234-238, 2011.
DOI : 10.1038/nature09917

A. Hernandez-hernandez, P. Ray, G. Litos, M. Ciro, S. Ottolenghi et al., Acetylation and MAPK phosphorylation cooperate to regulate the degradation of active GATA-1, The EMBO Journal, vol.14, issue.14, pp.3264-3274, 2006.
DOI : 10.1038/sj.emboj.7601228

A. Ianari, R. Gallo, M. Palma, E. Alesse, and A. Gulino, Specific Role for p300/CREB-binding Protein-associated Factor Activity in E2F1 Stabilization in Response to DNA Damage, Journal of Biological Chemistry, vol.279, issue.29, pp.30830-30835, 2004.
DOI : 10.1074/jbc.M402403200

A. Insinga, S. Minucci, and P. Pelicci, Mechanisms of Selective Anticancer Action of Histone Deacetylase Inhibitors, Cell Cycle, vol.4, issue.6, pp.741-743, 2005.
DOI : 10.4161/cc.4.6.1717

A. Insinga, S. Monestiroli, S. Ronzoni, V. Gelmetti, F. Marchesi et al., Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway, Nature Medicine, vol.61, issue.1, pp.71-76, 2005.
DOI : 10.1038/nm828

G. Lagger, O. Carroll, D. Rembold, M. Khier, H. Tischler et al., Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression, The EMBO Journal, vol.21, issue.11, pp.2672-2681, 2002.
DOI : 10.1093/emboj/21.11.2672

C. Leduc, P. Claverie, B. Eymin, E. Col, S. Khochbin et al., p14ARF promotes RB accumulation through inhibition of its Tip60-dependent acetylation, Oncogene, vol.24, issue.30, pp.4147-4154, 2006.
DOI : 10.1038/sj.onc.1209446
URL : https://hal.archives-ouvertes.fr/inserm-00175814

F. Mateo, M. Vidal-laliena, N. Canela, L. Busino, M. Martinez-balbas et al., Degradation of cyclin A is regulated by acetylation, Oncogene, vol.1786, issue.29, pp.2654-2666, 2009.
DOI : 10.1016/j.molcel.2008.02.027

C. Mercurio, S. Minucci, and P. Pelicci, Histone deacetylases and epigenetic therapies of hematological malignancies, Pharmacological Research, vol.62, issue.1, pp.18-34, 2010.
DOI : 10.1016/j.phrs.2010.02.010

S. Minucci and P. Pelicci, Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer, Nature Reviews Cancer, vol.105, issue.1, pp.38-51, 2006.
DOI : 10.1038/nrc1779

P. Mulligan, F. Yang, D. Stefano, L. Ji, J. Ouyang et al., A SIRT1-LSD1 Corepressor Complex Regulates Notch Target Gene Expression and Development, Molecular Cell, vol.42, issue.5, pp.689-699, 2011.
DOI : 10.1016/j.molcel.2011.04.020

A. Nebbioso, N. Clarke, E. Voltz, E. Germain, C. Ambrosino et al., Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells, Nature Medicine, vol.93, issue.1, pp.77-84, 2005.
DOI : 10.1126/SCIENCE.1068999
URL : https://hal.archives-ouvertes.fr/hal-00187707

W. Pear, J. Aster, M. Scott, R. Hasserjian, B. Soffer et al., Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles, Journal of Experimental Medicine, vol.183, issue.5, 1996.
DOI : 10.1084/jem.183.5.2283

N. Pediconi, A. Ianari, A. Costanzo, L. Belloni, R. Gallo et al., Differential regulation of E2F1 apoptotic target genes in response to DNA damage, Nature Cell Biology, vol.5, issue.6, pp.552-558, 2003.
DOI : 10.1038/ncb998

R. Piekarz, D. Sackett, and S. Bates, Histone Deacetylase Inhibitors and Demethylating Agents: Clinical Development of Histone Deacetylase Inhibitors for Cancer Therapy, The Cancer Journal, vol.13, issue.1, pp.30-39, 2007.
DOI : 10.1097/PPO.0b013e31803c73cc

P. Puri, V. Sartorelli, X. Yang, Y. Hamamori, V. Ogryzko et al., Differential Roles of p300 and PCAF Acetyltransferases in Muscle Differentiation, Molecular Cell, vol.1, issue.1, pp.35-45, 1997.
DOI : 10.1016/S1097-2765(00)80005-2

I. Screpanti, D. Bellavia, A. Campese, L. Frati, and A. Gulino, Notch, a unifying target in T-cell acute lymphoblastic leukemia?, Trends in Molecular Medicine, vol.9, issue.1, pp.30-35, 2003.
DOI : 10.1016/S1471-4914(02)00003-5

M. Stockhausen, J. Sjolund, C. Manetopoulos, and H. Axelson, Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells, British Journal of Cancer, vol.122, issue.4, pp.751-759, 2005.
DOI : 10.1074/jbc.M104309200

C. Talora, A. Campese, D. Bellavia, M. Pascucci, S. Checquolo et al., Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma, EMBO reports, vol.15, issue.11, pp.1067-1072, 2003.
DOI : 10.1038/sj.embor.7400013

C. Talora, S. Cialfi, C. Oliviero, R. Palermo, M. Pascucci et al., Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesis, Blood, vol.107, issue.8, pp.3313-3320, 2006.
DOI : 10.1182/blood-2005-07-2823

C. Talora, D. Sgroi, C. Crum, and G. Dotto, Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation, Genes & Development, vol.16, issue.17, pp.2252-2263, 2002.
DOI : 10.1101/gad.988902

M. Tsapis, M. Lieb, F. Manzo, P. Shankaranarayanan, R. Herbrecht et al., HDAC inhibitors induce apoptosis in glucocorticoid-resistant acute lymphatic leukemia cells despite a switch from the extrinsic to the intrinsic death pathway, The International Journal of Biochemistry & Cell Biology, vol.39, issue.7-8, pp.1500-1509, 2007.
DOI : 10.1016/j.biocel.2007.03.009
URL : https://hal.archives-ouvertes.fr/hal-00189170

A. Vacca, M. Felli, R. Palermo, D. Mario, G. Calce et al., Notch3 and pre-TCR interaction unveils distinct NF-??B pathways in T-cell development and leukemia, The EMBO Journal, vol.22, issue.5, pp.1000-1008, 2006.
DOI : 10.1038/sj.emboj.7600996

B. Zhang, A. Strauss, S. Chu, M. Li, Y. Ho et al., Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate, Cancer Cell, vol.17, issue.5, pp.427-442, 2010.
DOI : 10.1016/j.ccr.2010.03.011